BioCentury
ARTICLE | Clinical News

Multimeric-001 Universal Flu Vaccine: Additional Phase II data

August 10, 2015 7:00 AM UTC

An analysis of blood plasma samples from 120 elderly volunteers aged 65 and older who were treated 3 years ago in the double-blind, Israeli Phase II BVX-005 trial showed that >=50% of subjects who rec...